Merck, U6750-100MG, Uridine 5′-triphosphate trisodium salt hydrate

Size:100 mg, UTP Na₃, Type IV, ≥93.0% (HPLC)
Catalog Number: U6750-100MG
Pricing

Send a RFQ.

View RFQ List
Pack Size100 mg
Manufacturer's Pagewww.sigmaaldrich.com/US/en/product/SIGMA/U6750
Description
Application
UTP has been used as a P2 receptor activator to study its effects on proton efflux in MC3T3-E1 and UMR-106 cells. UTP has also been studied in combination with amiloride hydrochloride in nebulizer solutions for treating cystic fibrosis.
Uridine 5′-triphosphate has been used in a study to show that fluoxetine (FLX), mediates its anti-depressive effect by increasing the gliotransmission of adenosine 5′-triphosphate (ATP).
Biochem/physiol Actions
P2Y receptor agonist.
Uridine-5′-Triphosphate (UTP) is a cytosolic nucleotide component of nucleic acids. It serves as a signaling molecule in the extracellular space. Uridine-5′-Triphosphate (UTP) is involved in various pathophysiological responses in the nervous system. UTP also plays a major role in the regeneration process.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Preparation Note
25 mg of Uridine 5′-triphosphate trisodium salt (UTP Na₃) hydrate is soluble in 0.5 ml of water and yields a clear, colorless solution.
Specifications

General

Web Name Suffix Override≥93.0% (HPLC), Thyroid hormone
NACRESNA.77
PubChem Substance ID24900658
UNSPSC Code12352200
EC Number243-347-5
MDL numberMFCD00044310
Beilstein/REAXYS Number3585234
InChI keyMMJGIWFJVDOPJF-LLWADOMFSA-K
InChI1S/C9H15N2O15P3.3Na/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18;;;/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18);;;/q;3*+1/p-3/t4-,6-,7-,8-;;;/m1.../s1
SMILES string[Na+].[Na+].[Na+].O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)N2C=CC(=O)NC2=O
typeType IV
assay≥93.0% (HPLC)
solubilityH2O: soluble 25 mg of UTP in 0.5 ml of solvent, clear, colorless
storage temp.−20°C
Quality Level200